Drugs With Fewest Side-Effects for Treating Irritable Bowel Syndrome Identified, Study Suggests - ScienceDaily
|
Cedars-Sinai researchers have determined that two prevalent drug therapies -- rifaximin and lubiprostone -- offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings, based on an analysis of more than two dozen large-scale clinical trials, are contained in a peer-reviewed study published online by The American Journal of Medicine and set to appear in the publication's April print edition. ... Besides Cedars-Sinai, other centers participating in the research included the School of Medicine at Texas Tech University's Health Sciences Center; the UCLA Department of Medicine; Beth Israel Deaconess Medical Center; and Harvard Medical School. Read the full story >> |
Related Stories
How Does Your Garden Grow?
As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.
Adopt a Growth Mindset for a Better Life
A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.
Drug Use, Family History Can Lead to Heart Disease in Younger Adults
Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.
Recent Stories
PAs and Telehealth: Increasing Access to Patient Care
The PA profession and telehealth were both created to improve and expand access to patient care. PA Abby Buterbaugh discussed the value that her profession and telehealth has brought to health care.
Food Allergy Awareness, Prevention Ahead of Summer Fun
James Tarbox, M.D., Texas Tech Physicians allergist, discussed food allergies and treatments.
National Academy of Inventors Ranks Texas Tech University System Among Top 100 in Patents for Second Consecutive Year
The TTU System, including the TTUHSC and TTUHSC El Paso, ranked 74th on the NAI list of Top 100 U.S. Universities Granted Utility Patents for 2023.